It’s been over a decade since a new drug came on the market for dementia, but that’s not due to a lack of trying. Hear from Dr John Davis about the challenges involved with discovering new dementia medicines and innovative ways that scientists are working to overcome them.
Dr John Davis is Chief Scientific Officer at the Alzheimer’s Research UK Oxford Drug Discovery Institute, which focuses on novel targets in the dementia therapeutic area. The Institute brings together researchers from Biology, Chemistry, Psychiatry, and Neuroscience, and is part of a newly formed, world-class, network of three drug discovery institutes, sponsored by Alzheimer’s Research UK.
IF Oxford is operating a Pay What You Decide (PWYD) ticketing system. This works by enabling you to pre-book events without paying for a ticket beforehand. Aferwards, you have the opportunity to pay what you decide you want to, or can afford. If you prefer, you can make a donation when you book.
There may be tickets available on the door – spaces may be reallocated if ticket holders are late.
Start Time: 19:30
End Time: 18:30